CAM
TNGX icon

Congress Asset Management’s Tango Therapeutics TNGX Stock Holding History

Congress Asset Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9M Buy
380,746
+39,385
+12% +$974K 0.07% 203
2026
Q1 		$7.14M Buy
341,361
+106,733
+45% +$1.49M 0.05% 232
2025
Q4 		$2.08M Buy
234,628
+6,508
+3% +$56.1K 0.01% 279
2025
Q3 		$1.92M Buy
228,120
+926
+0.4% +$6.27K 0.01% 286
2025
Q2 		$1.16M Sell
227,194
-167
-0.1% -$413 0.01% 311
2025
Q1 		$311K Sell
227,361
-628
-0.3% -$1.54K ﹤0.01% 348
2024
Q4 		$704K Buy
227,989
+18,919
+9% +$87.8K ﹤0.01% 332
2024
Q3 		$1.61M Sell
209,070
-2,100
-1% -$20K 0.01% 287
2024
Q2 		$1.81M Buy
+211,170
New +$1.63M 0.01% 281

Other funds holding TNGX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Congress Asset Management's TNGX Position: Q2 2026 in Review

Congress Asset Management increased its Tango Therapeutics (TNGX) stake by 12% in Q2 2026, buying an estimated $974K and bringing the position to 380,746 shares worth $11.9M. The position accounts for 0.07% of the portfolio, ranked #203.

Congress Asset Management first reported a position in TNGX in Q2 2024 and has held it in 9 quarters since. 8 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Congress Asset Management held 380,746 shares of Tango Therapeutics worth $11.9M as of Q2 2026.
  • Congress Asset Management bought 39,385 Tango Therapeutics shares in Q2 2026, an estimated $974K.
  • Tango Therapeutics made up 0.07% of Congress Asset Management's portfolio in Q2 2026, its #203 holding.
  • Congress Asset Management first reported a position in Tango Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 8 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Congress Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.